Abstracts - faqs.org

Abstracts

News, opinion and commentary

Search abstracts:
Abstracts » News, opinion and commentary

Deal may cut state's Medicaid payouts

Article Abstract:

Bayer AG has agreed to pay $14 million to settle claims by US federal and state prosecutors that the company mispresented wholesale prices of certain drugs to gain market advantage. As part of the settlement of the drug-pricing case, the German drugmaker also promised to report to states what it actually charges for prescription drug products, rather than falsely inflate wholesale prices. With such policy, prosecutors believe that doctors will not anymore be able to overcharge state health programs for drugs.

Author: Appleby, Julie
Publisher: USA Today
Publication Name: USA Today
Subject: News, opinion and commentary
ISSN: 0734-7456
Year: 2001
Bayer AG

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Drug companies face accusations about pricing

Article Abstract:

The attorney general of Texas is seeking $79 million in damages from three drug companies for allegedly cheating the state's Medicaid program by inflating the prices of respiratory drugs. These companies are Warrick Pharmaceuticals, Dey Laboratories and Roxane Laboratories. Congress is also investigating executives of SmithKline Beecham, which declined to turn over five documents and plan to investigate Glaxo Welcome officials afterwards.

Author: Appleby, Julie
Publisher: USA Today
Publication Name: USA Today
Subject: News, opinion and commentary
ISSN: 0734-7456
Year: 2000

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Drug makers accused of price scheme

Article Abstract:

Government investigators have discovered documents showing that drug companies deliberately manipulate prices so that doctors can overcharge Medicare and promote this profit-making strategy to physicians. These documents, which were released by the House Commerce Committee on Sep 26, 2000, also suggest that this manipulative practice of drug companies may cost government health programs and patients $1 billion a year.

Author: Appleby, Julie
Publisher: USA Today
Publication Name: USA Today
Subject: News, opinion and commentary
ISSN: 0734-7456
Year: 2000

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: United States, Drugs
Similar abstracts:
  • Abstracts: Digital phone service routs analog. AT&T makes Net portable, free. AT&T launches biggest IPO today
  • Abstracts: Nortel may sell shares in fiber-optics parts unit. Corning may buy Nortel business. Global Crossing claims Tyco stole trade secrets
  • Abstracts: Fliers go the distance to avoid paying high airfares. Frustrated travelers shun United for on-time flights
  • Abstracts: Rentals soar as stores do battle. Giant retailers shift, sell more appliances. Circuit City to cut appliances; Kmart will shut 72 stores
  • Abstracts: As Brazil's market grows, so does the free access dispute. Brazil's hot commodity? Not coffee or soccer. The Devil Take August. In Brazil, It's Just Too Scary
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.